Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Adam C. Strauss"'
Autor:
Adam C. Strauss, Zahir Kanjee, Sophia H. Yin, Youjin Jenny Jang, Michelle S. Lee, Abraham Z. Cheloff
Publikováno v:
The Clinical Teacher. 19:48-51
BACKGROUND: Although the COVID-19 pandemic increased social isolation among hospitalised patients given isolation precautions, visitor restrictions and curtailed interactions with healthcare teams, medical students had limited opportunities for invol
Autor:
Emeric F Bojarski, Adam C Strauss, Adam P Fagin, Theo S Plantinga, Alexander Hoischen, Joris Veltman, Stephen A Allsop, Victor J Anciano Granadillo, Arsani William, Mihai G Netea, Jordan Dimitrakoff
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68118 (2013)
A 44-year-old man is presented here with 14 years of chronic purulent sinusitis, a chronic fungal rash of the scrotum, and chronic pelvic pain. Treatment with antifungal therapy resulted in symptom improvement, however he was unable to establish an e
Externí odkaz:
https://doaj.org/article/b3a704d226e64dc4a500fb8dac6af28f
Autor:
Adam C. Strauss, Elizabeth R. Unger, Leonard A. Jason, Arsani William, Gailen D. Marshall, Jordan D. Dimitrakoff, David Fischer
Publikováno v:
Fatigue: Biomedicine, Health & Behavior. 2:93-109
Background: Chronic fatigue syndrome (CFS) remains an incompletely characterized illness, in part due to controversy regarding its definition, biological basis, and diagnosis. Purpose: Biomarkers are objective measures that may lead to improvements i
Autor:
Charles J. Lightdale, Stuart R. Gordon, John R. Saltzman, Agoston T. Agoston, Julian A. Abrams, Robert D. Odze, Amitabh Srivastava, Alona Muzikansky, David I. Fudman, Parambir S. Dulai, Richard I. Rothstein, Kunal Jajoo, Gregory Y. Lauwers, Catherine Hagen, David G. Forcione, Adam C. Strauss
Publikováno v:
The American journal of surgical pathology. 40(4)
Radiofrequency ablation (RFA), with or without endoscopic mucosal resection (EMR), is a safe, effective, and durable treatment option for Barrett esophagus (BE)-associated dysplasia (DYS), but few studies have identified predictors of treatment failu
Autor:
Jordan D. Dimitrakoff, Arsani William, Mihai G. Netea, Emeric Bojarski, Adam C. Strauss, Stephen A. Allsop, Alexander Hoischen, Theo S. Plantinga, Victor J. Anciano Granadillo, Joris A. Veltman, Adam P. Fagin
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 7, p e68118 (2013)
PLoS One, 8
PLoS One, 8, 7
PLoS ONE, Vol 8, Iss 7, p e68118 (2013)
PLoS One, 8
PLoS One, 8, 7
Contains fulltext : 140537.pdf (Publisher’s version ) (Open Access) A 44-year-old man is presented here with 14 years of chronic purulent sinusitis, a chronic fungal rash of the scrotum, and chronic pelvic pain. Treatment with antifungal therapy re
Autor:
Leonard D. Shultz, Adam C. Strauss, Tessa L. Holyoake, YinWei Ho, Keh-Dong Shiang, Bin Zhang, Su Chu, Min Li, Claudia S. Huettner, Ravi Bhatia, David S. Snyder
SummaryImatinib mesylate (IM) induces remission in chronic myelogenous leukemia (CML) patients but does not eliminate leukemia stem cells (LSCs), which remain a potential source of relapse. Here we investigated the ability of HDAC inhibitors (HDACis)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d2152dbae058dca9c4739c644eafcd6
https://europepmc.org/articles/PMC2873971/
https://europepmc.org/articles/PMC2873971/
Autor:
Jordan Dimitrakov, Adam C. Strauss
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition among men of a wide age range, with detrimental effects on quality of life. The etiology, pathogenesis, and optimal treatment of CP/CPPS remain unknown, although progres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9b28b858f6ed7063a1d892389e12429
https://europepmc.org/articles/PMC2837110/
https://europepmc.org/articles/PMC2837110/
Autor:
Gregory Y. Lauwers, Amitabh Srivastava, Robert D. Odze, Richard I. Rothstein, David I. Fudman, Catherine Hagen, Charles J. Lightdale, Stuart R. Gordon, Kunal Jajoo, Agoston T. Agoston, David G. Forcione, John R. Saltzman, Adam C. Strauss, Julian A. Abrams, Parambir S. Dulai
Publikováno v:
Gastroenterology. 146:S-660
Autor:
Lenny Shultz, Tessa L. Holyoake, Adam C. Strauss, Yin Wei Ho, Bin Zhang, Ravi Bhatia, David S. Snyder, Claudia S. Huettner, Su Chu
Publikováno v:
Blood. 114:190-190
Abstract 190 The BCR-ABL tyrosine kinase inhibitor imatinib mesylate (IM) is highly effective in inducing remissions and improving survival in CML patients but fails to eliminate leukemia stem cells, which remain a potential source of relapse. Quiesc
Publikováno v:
Blood. 110:1031-1031
Imatinib mesylate (IM) is highly effective in the treatment of chronic myeloid leukemia (CML). However IM does not eliminate quiescent, primitive CML hematopoietic cells, which persist through treatment and remain a potential source of relapse. There